SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Barclays Maintains Equal-Weight Rating on Gilead Sciences, Raises Target to $160

Barclays maintained its Equal-Weight rating on Gilead Sciences and raised its price target to $160 per share from $145.

GILD

Related stories